Notice of Exempt Offering of Securities, item 06b

> X0707 D LIVE 0001385818 AYTU BIOSCIENCE, INC 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO COLORADO 80112 (720) 437-6580 DELAWARE AYTU BIOSCIENCE, INC. Rosewind CORP Corporation true 2015 Joshua R. Disbrow c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Director Jarrett T. Disbrow c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Gregory A. Gould c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Michael Macaluso c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Carl C. Dockery c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director John A. Donofrio, Jr. c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Gary V. Cantrell c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Pharmaceuticals Decline to Disclose 06b false 2017-05-05 false true true Pursuant to a Merger Agreement, the Issuer issued 2,500,000 shares of common stock to certain stockholders of Nuelle, Inc., a Delaware corporation, pursuant to the terms and conditions of the merger. 0 Indefinite 1750000 Indefinite The total offering amount may be up to a maximum of $6,925,000 in earnout payments and up to a maximum of $24,000,000 in milestone payments under the Merger Agreement. false 16 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false AYTU BIOSCIENCE, INC /s/ Joshua Disbrow Joshua Disbrow Chief Executive Officer 2017-05-12

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Rosewind CORP makes a similar move, sign up!

Other recent filings from the company include the following:

General form for registration of securities under the Securities Act of 1933 - Sept. 25, 2017
General form for registration of securities under the Securities Act of 1933 - Sept. 22, 2017
General form for registration of securities under the Securities Act of 1933 - Sept. 5, 2017
Rosewind: Aytu Bioscience Provides Fiscal Fourth Quarter And Year-End 2017 Business Update - Aug. 31, 2017
Rosewind CORP Just Filed Its Annual Report: Note 14 – Subsequ... - Aug. 31, 2017

Auto Refresh

Feedback